Efficacy and Safety of Semaglutide Versus Dulaglutide as add-on to Metformin in Subjects With Type 2 Diabetes.
Clinical trial NCT02648204 · COMPLETED
Trial details
- NCT number
- NCT02648204
- Sponsor
- Novo Nordisk A/S
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2016-01-06
- Primary completion
- 2017-04-10
- Enrollment
- 1201
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.